Correlation Between Fulgent Genetics and NeuroMetrix

Can any of the company-specific risk be diversified away by investing in both Fulgent Genetics and NeuroMetrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fulgent Genetics and NeuroMetrix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fulgent Genetics and NeuroMetrix, you can compare the effects of market volatilities on Fulgent Genetics and NeuroMetrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fulgent Genetics with a short position of NeuroMetrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fulgent Genetics and NeuroMetrix.

Diversification Opportunities for Fulgent Genetics and NeuroMetrix

-0.29

Correlation Coefficient

Fulgent Genetics  NeuroMetrix

Very good diversification

The 3 months correlation between Fulgent and NeuroMetrix is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Fulgent Genetics and NeuroMetrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroMetrix and Fulgent Genetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fulgent Genetics are associated (or correlated) with NeuroMetrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroMetrix has no effect on the direction of Fulgent Genetics i.e., Fulgent Genetics and NeuroMetrix go up and down completely randomly.

Pair Corralation between Fulgent Genetics and NeuroMetrix

Given the investment horizon of 90 days Fulgent Genetics is expected to under-perform the NeuroMetrix. But the stock apears to be less risky and, when comparing its historical volatility, Fulgent Genetics is 1.17 times less risky than NeuroMetrix. The stock trades about -0.03 of its potential returns per unit of risk. The NeuroMetrix is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  405.00  in NeuroMetrix on September 12, 2024 and sell it today you would lose (2.00) from holding NeuroMetrix or give up 0.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Fulgent Genetics  vs.  NeuroMetrix

Fulgent Genetics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fulgent Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Fulgent Genetics is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

NeuroMetrix

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in NeuroMetrix are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, NeuroMetrix is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Fulgent Genetics and NeuroMetrix

The main advantage of trading using opposite Fulgent Genetics and NeuroMetrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fulgent Genetics position performs unexpectedly, NeuroMetrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroMetrix will offset losses from the drop in NeuroMetrix's long position.

The idea behind Fulgent Genetics and NeuroMetrix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.